An important DAMP that activates the Nlrp3 inflammasome after myeloablative conditioning for hematopoietic transplantation and that triggers GvHD is crystalized uric acid [114], the final breakdown product of purine metabolism released from ischemic tissues and dying cells [115]. Here, NLRP3 is linked to graft versus host disease.